Nuclear Medicine

What side effects do patients report after Pluvicto therapy?

By Will Morton

Fatigue, pain flare, nausea, and urinary symptoms are among the most commonly reported immediate side effects of Pluvicto therapy.

June 5, 2026

SNMMI ShowCast Roundup

By Will Morton

Science was the star in Los Angeles at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 5, 2026

Radiopharmaceutical manufacturers report uneven FDA inspections

By Liz Carey

RMTA lays out radiopharmaceutical regulatory and payment policy issues.

June 4, 2026

Alpha Tau, Tolmar strike $196M deal to commercialize Alpha DaRT

By AuntMinnie.com staff writers

Tolmar will make a $20 million equity investment in Alpha Tau at closing and contribute $15 million toward construction of a new U.S. production facility.

June 3, 2026

SNMMI awards Martin Pomper 2026 Benedict Cassen Prize

By AuntMinnie.com staff writers

The SNMMI has awarded Martin Pomper, MD, PhD, the Benedict Cassen Prize for his contributions toward nuclear medicine research.

June 1, 2026

ASCO: Lu-177 edotreotide yields sustained quality-of-life gains

By Erik L. Ridley

A poster presentation at ASCO 2026 highlighted quantifiable benefits for patients receiving the radiopharmaceutical treatment for GEP-NETs.

May 31, 2026

Archeus doses first patient in phase I RPT trial

By AuntMinnie.com staff writers

In preclinical work, Y-90 ARC-706 demonstrated tumor-selective uptake across multiple ICI-treated cancers.

May 27, 2026

Mevion to install first proton therapy system in Vietnam

By AuntMinnie.com staff writers

Mevion Medical Systems has signed an agreement to install what the firm says will be the first proton therapy system in Vietnam.

May 26, 2026

Radnostix reports 27% revenue decline in Q1

By AuntMinnie.com staff writers

Radnostix reported a 27% decrease in the first quarter of 2026 compared to the previous year's first quarter.

May 21, 2026

Niowave breaks ground on $75M Mich. Ac-225 production facility

By AuntMinnie.com staff writers

Niowave has broken ground on its Ac-225 production facility in Lansing, MI, with construction expected to be finished by 2028.

May 21, 2026

NRC to ease burden on radiopharmaceutical licensees

By AuntMinnie.com staff writers

The rule would eliminates decommissioning financial assurance (DFA) for all radionuclides with half-lives of 120 days or less.

May 19, 2026

Plus Therapeutics inks AI deal with Ephemeral Technologies

By AuntMinnie.com staff writers

Plus Therapeutics is a clinical-stage pharmaceutical company developing radiopharmaceutical therapies for CNS cancers.

May 19, 2026

Page 1 of 443

Next Page